Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5053
Gene Symbol: PAH
PAH
0.080 Biomarker disease BEFREE This first randomised trial in PAH/CTEPH patients with exercise-induced hypoxaemia demonstrates that DOXT improves exercise capacity, quality of life and functional class. 31073087 2019
Entrez Id: 5053
Gene Symbol: PAH
PAH
0.080 Biomarker disease BEFREE <b>Expert opinion</b>: Drugs approved for PAH have recently shown excellent efficacy in patients with non-operable CTEPH. 31545126 2019
Entrez Id: 5053
Gene Symbol: PAH
PAH
0.080 Biomarker disease BEFREE This is the first systematic review and meta-analysis of randomized controlled trials revealing a positive role of PAH-targeted therapies in CTEPH. 31059198 2019
Entrez Id: 5053
Gene Symbol: PAH
PAH
0.080 Biomarker disease BEFREE In this review, we summarize the achievements and unresolved problems of PAH-targeted therapy for CTEPH over the last decade. 31044326 2019
Entrez Id: 5053
Gene Symbol: PAH
PAH
0.080 Biomarker disease BEFREE Whether daily activity assessments provide additional information to simple walk distance on risk factor profiles during follow-up in patients with PAH/CTEPH remains to be clarified. 31263960 2019
Entrez Id: 5053
Gene Symbol: PAH
PAH
0.080 Biomarker disease BEFREE Correction to: Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH. 29616325 2018
Entrez Id: 5053
Gene Symbol: PAH
PAH
0.080 Biomarker disease BEFREE In patients with PAH/CTEPH, very short-term exposure to moderate hypoxia similar to 2600 m altitude or during commercial air travel did not deteriorate hemodynamics. 29891241 2018
Entrez Id: 5053
Gene Symbol: PAH
PAH
0.080 Biomarker disease BEFREE Patients with PAH/CTEPH may therefore benefit from oxygen therapy during daily physical activities and training. 28329240 2017
Entrez Id: 659
Gene Symbol: BMPR2
BMPR2
0.030 GeneticVariation disease BEFREE Mutations in BMPR2, differential gene and microRNA expression, and the transcription factor FoxO1 have been suggested to be involved in the processes underlying the development of CTEPH. 30759794 2019
Entrez Id: 659
Gene Symbol: BMPR2
BMPR2
0.030 GeneticVariation disease BEFREE It is the first report of a BMPR2 mutation in CTEPH. 24728306 2014
Entrez Id: 659
Gene Symbol: BMPR2
BMPR2
0.030 GeneticVariation disease BEFREE In a cohort of Swiss patients with IPAH (n = 16) and CTEPH (n = 16), and in 24 controls with left heart disease without PH, polymorphisms in the BMPR2, 5-HHT, 5-HTR-2A and eNOS genes were analyzed and correlated with various clinical, functional and hemodynamic parameters. 19844076 2010
Entrez Id: 1906
Gene Symbol: EDN1
EDN1
0.020 Biomarker disease BEFREE Activated Endothelial TGFβ1 Signaling Promotes Venous Thrombus Non-Resolution in Mice Via Endothelin-1: Potential Role for Chronic Thromboembolic Pulmonary Hypertension. 31747868 2020
Entrez Id: 2308
Gene Symbol: FOXO1
FOXO1
0.020 AlteredExpression disease BEFREE Mutations in BMPR2, differential gene and microRNA expression, and the transcription factor FoxO1 have been suggested to be involved in the processes underlying the development of CTEPH. 30759794 2019
Entrez Id: 1906
Gene Symbol: EDN1
EDN1
0.020 GeneticVariation disease BEFREE In 385 consecutive patients diagnosed with CTEPH who underwent PEA at the Foundation IRCC Policlinico San Matteo (Pavia, Italy) from January 2009 to April 2015, we assessed preoperative circulating ET-1 by ELISA and identified presence of AKI based on 2012 KDIGO criteria. 30229506 2018
Entrez Id: 2308
Gene Symbol: FOXO1
FOXO1
0.020 AlteredExpression disease BEFREE Both the mRNA and protein levels of FoxO1 decreased in the CTEPH rats compared to in the sham group. 28536427 2017
Entrez Id: 1361
Gene Symbol: CPB2
CPB2
0.020 AlteredExpression disease BEFREE Moreover, plasma levels of TAFIa were increased 10-fold in CTEPH patients compared with controls. 28289017 2017
Entrez Id: 1361
Gene Symbol: CPB2
CPB2
0.020 AlteredExpression disease BEFREE Moreover, plasma levels of TAFI were significantly higher in CTEPH than in pulmonary arterial hypertension or controls (19.4±4.2 versus 16.1±4.5 or 16.3±3.3 μg/mL, both P<0.05), which remained unchanged even after hemodynamic improvement by percutaneous transluminal pulmonary angioplasty. 27102961 2016
Entrez Id: 3106
Gene Symbol: HLA-B
HLA-B
0.020 Biomarker disease BEFREE The predominance of chronic thromboembolic pulmonary hypertension (CTEPH) in females and association of HLA-B*5201 with CTEPH have been reported in Japan. 18931448 2008
Entrez Id: 3106
Gene Symbol: HLA-B
HLA-B
0.020 Biomarker disease BEFREE These observations suggested that both the susceptibility and clinical characteristics of chronic thromboembolic pulmonary hypertension were controlled in part by the HLA-B and -DPB1 loci. 15640334 2005
Entrez Id: 5478
Gene Symbol: PPIA
PPIA
0.010 Biomarker disease BEFREE Cyclophilin A as a biomarker for the therapeutic effect of balloon angioplasty in chronic thromboembolic pulmonary hypertension. 31615744 2020
Entrez Id: 7046
Gene Symbol: TGFBR1
TGFBR1
0.010 AlteredExpression disease BEFREE Increased circulating active TGFβ1 levels, endothelial TGFβRI/ALK1 and TGFβRI/ALK5 expression were detected in End.TGFβRII-KO mice, and activated TGFβ signaling was present in vessel-rich areas of CTEPH specimens. 31747868 2020
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.010 Biomarker disease BEFREE Activated Endothelial TGFβ1 Signaling Promotes Venous Thrombus Non-Resolution in Mice Via Endothelin-1: Potential Role for Chronic Thromboembolic Pulmonary Hypertension. 31747868 2020
Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A
0.010 Biomarker disease BEFREE Finally, miRNA-149-5p-PDGFRB-TCONS_l2_00020587-XLOC_l2_010723 and miRNA-338-5p/miRNA-199b-5p-HIF1A- TCONS_l2_00020587-XLOC_l2_010723 were found in the analysis of the network.miRNA-149-5p-PDGFRB-lncRNA CTEPH-associated 1 (CTEPHA1) (TCONS_l2_00020587-XLOC_l2_010723) and miRNA-338-5p/miRNA-199b-5p-HIF1A-lncRNA CTEPHA1 are related to the development of CTEPH. 31204374 2019
Entrez Id: 4353
Gene Symbol: MPO
MPO
0.010 AlteredExpression disease BEFREE Apart from key differences between Austrian and Japanese patients regarding body size, lung function vital capacity, cardiac output, and serum high-density lipoprotein levels, Austrian patients were more likely to be obese, have greater hematocrits and greater white blood cells counts, greater C-reactive protein levels, and significantly elevated serum myeloperoxidase levels compared with Japanese patients with CTEPH. 31084984 2019
Entrez Id: 6696
Gene Symbol: SPP1
SPP1
0.010 Biomarker disease BEFREE The results of the present observational translational study point to a possible involvement of OPN in the pathogenesis of CTEPH by affecting early inflammatory and late fibrotic processes. 31183846 2019